Effect of COVID-19 Infection on Obstertric Complications and Maternal Outcomes

CompletedOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
COVID-19InfectionObstetric ComplicationMaternal Outcomes
Interventions
OTHER

Data collection

Data collected included maternal demographics, medication during pregnancy, the gestational week when COVID-19 was diagnosed, antenatal diseases occurring after COVID-19 detection during pregnancy, intrauterine growth retardation (IUGR), small for gestational age (SGA), fetal distress, intrauterine fetal demise (IUFD), intrapartum complications, gestational age (GA) at delivery, mode of delivery, postpartum hemorrhage (PPH), admission to the maternal ICU, birth weight, admission to the NICU, and the indication for NICU hospitalization Pregnancy outcomes included mode of delivery, gestational age at delivery, pre-eclampsia, and postpartum hemorrhage (defined as an estimated blood loss of 1,000 mL or greater).

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06557694 - Effect of COVID-19 Infection on Obstertric Complications and Maternal Outcomes | Biotech Hunter | Biotech Hunter